Drug discovery services are designed specifically to enable efficient economies of scale in the process of drug discovery. The global drug discovery services market is expected to exhibit a lucrative CAGR of 10.8% over the forecast period of 2017-2023.
Market Research Future (MRFR), in their latest report, has mentioned many factors leading to a fast-paced acceleration of the Global Drug Discovery Services Market. The process of designing a new drug is called as drug discovery. Some of the most common methods deployed for effective drug discovery are molecular manipulation, drug metabolites, random screening, and serendipity. A rise observed in demand for cancer treatment has pushed sizeable growth in the global drug discovery services market. Further, technological advances and mounting healthcare expenditure are other primary factors contributing to the burgeoning drug discovery services market. As per the data published by the World Health Organization (WHO), cancer is one of the most significant causes of death across the globe. According to the data, cancer killed 8.8 million deaths in 2015.
Get a FREE Sample Copy@ https://www.marketresearchfuture.com/sample_request/5870
Market Segmentation:
The global drug discovery services market is studied for various segments on the basis of drug types, types of services, technology, therapeutic area, process, and end-user. Based on drug types, the global drug discovery services market is segmented into small molecule drugs and biologics drugs. Based on types of services, the drug discovery services market is segmented into drug metabolism and pharmacokinetics (DMPK) services, medicinal chemistry, pharmaceutical services, and biological services. Based on technology, the drug discovery services market is segmented into biochips, pharmacogenomics & pharmacogenetics, combinatorial chemistry, high throughput screening, nanotechnology, metabolomics, and spectroscopy.
Based on the therapeutic area, the global drug discovery services market is segmented into neurology, oncology, cardiovascular diseases, diabetes, and respiratory diseases. Based on the process, the drug discovery services market is segmented into target selection, target validation, hit-to-lead identification, lead optimization, and candidate validation. Based on end-user, the global drug discovery services market is segmented into pharmaceutical companies, biotechnology companies, research institutes, and hospitals & clinics.
Market Major Players Competitive Dashboard:
Some of the profiled market vendors include Abbott Laboratories Inc., Agilent Technologies Ubiquigent, Advinus Therapeutics, Albany Molecular Research Inc. (AMRI), Bayer AG, AstraZeneca PLC, Aurigene, Charles River Laboratories International, Covance, ChemBridge Corporation, Eli Lilly and Company, Domainex, Evotec, F. Hoffmann-La Roche Ltd, GenScript, GE Healthcare, GlaxoSmithKline LLC, Jubilant Biosys, GVK Biosciences, Lonza, Merck, Piramal Enterprises, Pharmaceutical Product Development, LLC (PPD), Promega Corporation, Shimadzu Corp., Selcia Limited, SRI International, Thermo Fisher Scientific, Syngene International Ltd., Viva Biotech, and WuXi AppTec.
LIST OF TABLES
Table 1 Drug Discovery Services Industry Synopsis, 2017–2023
Table 2 Drug Discovery Services Market Estimates and Forecast, 2017–2023, (USD Million)
Table 3 Drug Discovery Services Market, by Region, 2017–2023, (USD Million)
Table 4 Drug Discovery Services Market, by Drug Type, 2017–2023, (USD Million)
Table 5 Drug Discovery Services Market, by Types of Services, 2017–2023, (USD Million)
Table 6 Drug Discovery Services Market, by Technology, 2017–2023, (USD Million)
Table 7 Drug Discovery Services Market, by Therapeutic Area, 2017–2023, (USD Million)
Table 8 Drug Discovery Services Market, by Process, 2017–2023, (USD Million)
Table 9 Drug Discovery Services Market, by End-User, 2017–2023, (USD Million)
…To be Continued.
Access Complete Premium Research Details at: https://www.marketresearchfuture.com/reports/drug-discovery-services-market-5870
Industry Update
In 2019: Fujifilm and Axcelead Drug Discovery have formed a partnership to provide human induced pluripotent stem cell (iPSC)-based drug discovery services. The firms will offer iPCSs and iPCS-derived cells from a Fujifilm subsidiary ‘Fujifilm Cellular Dynamics’ along with Axcelead drug discovery services and customized drug evaluation and toxicity testing methods.
Detailed Regional Analysis
The drug discovery services market is regionally segmented into the Americas, Asia Pacific, Europe, and the Middle East & Africa. The Americas is expected to retain dominance over the drug discovery services market. This can be attributed to the increasing prevalence of chronic diseases and high healthcare expenditure. The Center for Disease Control & Prevention recently stated that approximately 92.1 million adults have at least one type of cardiovascular disease.
Europe is expected to follow behind the Americas and garner the second-largest share in the drug discovery services market over the forecast period. Such growth can be credited to the growing financial support provided by the government towards the research and development as well as the patent expiration of various blockbuster drugs. Different biologic drugs such as Genentech’s Rituxan, Abbott & Eisai’s Humira, and J&J’s Remicade are expected to lose their patent protection soon.
Asia Pacific is anticipated to be the fastest-growing drug discovery services market due to the growing patient pool in the region. Further, developments in the pharmaceutical sector are expected to push favorable growth in the regional drug discovery services market. The Middle East & Africa is holding the smallest share in the drug discovery services market owing to a sluggish development, lack of technical knowledge, and a poor healthcare sector.
Ask for an Amazing Discount at: https://www.marketresearchfuture.com/check-discount/5870
About Market Research Future: Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar, Pune – 411028
+1 646 845 9312
Email: sales@marketresearchfuture.com
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/drug-discovery-services-market-5870